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Abstract
Background: Obesity is known to be associated with higher risks of cardiovascular disease, metabolic syndrome,
and diabetes mellitus. Thyroid-stimulating hormone (TSHR) is the receptor for thyroid-stimulating hormone (TSH, or
thyrotropin), the key regulator of thyroid functions. The expression of TSHR, once considered to be limited to
thyrocytes, has been so far detected in many extrathyroidal tissues including liver and fat. Previous studies have
shown that TSHR expression is upregulated when preadipocytes differentiate into mature adipocytes, suggestive of
a possible role of TSHR in adipogenesis. However, it remains unclear whether TSHR expression in adipocytes is
implicated in the pathogenesis of obesity.
Methods: In the present study, TSHR expression in adipose tissues from both mice and human was analyzed, and
its association with obesity was evaluated.
Results: We here showed that TSHR expression was increased at both mRNA and protein levels when 3T3-L1
preadipocytes were induced to differentiate. Knockdown of TSHR blocked the adipocyte differentiation of 3T3-L1
preadipocytes as evaluated by Oil-red-O staining for lipid accumulation and by RT-PCR analyses of PPAR-g and
ALBP mRNA expression. We generated obesity mice (C57/BL6) by high-fat diet feeding and found that the TSHR
protein expression in visceral adipose tissues from obesity mice was significantly higher in comparison with the
non-obesity control mice (P < 0.05). Finally, the TSHR expression in adipose tissues was determined in 120 patients.
The results showed that TSHR expression in subcutaneous adipose tissue is correlated with BMI (body mass index).
Conclusion: Taken together, these results suggested that TSHR is an important regulator of adipocyte
differentiation. Dysregulated expression of TSHR in adipose tissues is associated with obesity, which may involve a
mechanism of excess adipogenesis.
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Background
Obesity, a condition of body characterized by over accu-
mulation of fat, is associated with increased risks of car-
diovascular disease, metabolic syndrome, and diabetes
mellitus [1,2]. However, the mechanism of obesity devel-
opment is not fully understood, and has become a focus
of extensive investigations. Generally, obesity occurs
when energy intake by an individual exceeds the rate of
energy expenditure. Adipose tissues are the major depots
for energy storage. Obesity is known to be directly linked
to the accumulation of body fat. At the cellular level, obe-
sity can be considered as a hypertrophic disease resulted
from an increase in the number or size of individual adi-
pocytes. New fat cells come from a preexisting popula-
tion of undifferentiated progenitor with high capability of
proliferation and differentiation. So far, numerous factors
or proteins have been implicated in the generation of
new fat cells, including peroxisome proliferator-activated
receptor g (PPAR-g, a member of the nuclear hormone
receptor), CCAAT/enhancer binding protein (C/EBP,
including C/EBP a, C/EBPb and C/EBPs), adipocyte lipid
binding protein (ALBP) and adipocyte determination and
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any medium, provided the original work is properly cited.differentiation factor 1 (ADD1) [3-5]. However, the rele-
vance of those factors to obesity is unclear.
Thyroid-stimulating hormone (TSH) receptor gene
(TSHR) encodes a transmembrane receptor which belongs
to a subfamily of heptahelical G protein coupled receptors.
In thyroid tissues, TSHR mediates the effects of TSH
released from the anterior pituitary, and plays critical roles
in thyroid development and function. Recent studies have
demonstrated that TSHR is also present in non-thyroid
tissues, such as hepatocyte [6] and adipocytes [7,8]. How-
ever, the physiological or pathological relevance of TSHR
in these non-thyroid tissues is not completely known and
is now under intensive investigations [9-12].
Several studies have suggested that TSHR expression in
adipocytes may play an important role for adipogenesis.
T. Onaya reported that the differentiation of rat preadipo-
cytes was accompanied by an increased expression of
TSHR [7]. Similar results were also observed in human
orbital preadipocyte fibroblasts [13,14] and in mouse
embryonic stem cells [15]. However, there have been
reports showing TSHR expression was negatively corre-
lated with adipogenesis [9]. The reason for the discrepancy
in the above observations is unknown. In the present
study, the association between adipocyte differentiation
and TSHR expression was investigated in murine 3T3-L1
preadipocytes. In addition, we determined the TSHR
expression in adipose tissues from both mice and human
samples, and the relevance of TSHR expression in adipo-
cytes to obesity was evaluated.
Results
Induction of differentiation in 3T3-L1 preadipocytes
3T3-L1 preadipocytes were induced to differentiate as
described in Materials and Methods. The differentiation
was evaluated by Oil-red-O staining for lipid accumula-
tion and by RT-PCR analyses of PPAR-g and ALBP
mRNA expression. As shown in Figure 1 (A, B), lipid
droplets could be detected by Oil-red-O staining as early
as day-4 post differentiation induction, and peaked on
day-12. To further verify the preadipocyte differentiation,
the expression of PPAR-g and ALBP, two essential regu-
lators and markers for adipocyte differentiation, was ana-
lyzed by RT-PCR. As shown in Figure 1(C, D), the
mRNA levels of PPAR-g and ALBP were significantly
increased on day-2 post induction of differentiation, and
peaked on day-12 (P < 0.05).
TSHR expression profile during the differentiation of 3T3-
L1 preadipocytes
T og e ti n s i g h tt ot h ep o s s i b l er o l eo fT S H Ri na d i p o g e n -
esis, TSHR mRNA and protein levels during the differen-
tiation of 3T3-L1 preadipocytes was analyzed. As shown
in Figure 2, TSHR mRNA level was significantly
increased 4 days after differentaition induction, and
peaked on day-12.
Consistent with the mRNA expression profile, the TSHR
protein was showed to be significantly increased on day-4,
and reached the peak on day-12 as determined by Western
blot (Figure 3A/B). Additionaly, TSHR protein expression
was analyzed by Laser scan confocal microscope following
immuno-fluorescence staining. As shown in Figure 3C/D,
TSHR protein expression was significantly higher in differ-
entiated adipocytes (12 days post induction) than that of
the undifferentiated 3T3-L1 preadipocytes.
Influence of Tshr gene knockdown on 3T3-L1
preadipocytes differentiation
To get insight to the role of TSHR in adipose differentia-
tion, Tshr gene expression was suppressed in 3T3-L1 prea-
dipocytes by siRNA-mediated knock-down, and its
influence on adipose differentiation was evaluated subse-
quently. As shown in Figure 4, siRNA treatment reduced
the TSHR mRNA and protein expression by (60.73 ±
5.56)% and (71.33 ± 7.02)%, respectively, compared to vec-
tor treated control cells. When induced to differentiate,
siRNA treated cells showed to have less intracellular lipid
accumulation and lower levels of PPAR-g and ALBP pro-
tein compared to vector treated control cells at each time
point (Figure 5). These results indicated that TSHR-
mediated signaling is necessary for adipose differentiation
of 3T3-L1 preadipocytes.
Increased TSHR protein expression in visceral adipose
tissues from obese mice
Obesse C57/BL6 mice were induced with high-fat diet for
14 weeks, while control mice were fed with ordinary diet.
At the end of experiments, the body weight, serum CHOL
and GLU levels were increased in obese mice compared to
the control mice (Table 1). In each group, TSHR protein
expression in visceral adipose tissues showed to increase
with increasing body weight. The average TSHR protein
level in obese mice was significantly increased compared
to control mice (Figure 6A/B).
Correlation between BMI and TSHR protein expression in
human subcontaneous adipose tissues
The TSHR protein expression in human adipose tissue
samples was analyzed by Western blot. Our results
showed that TSHR protein expression in human subcu-
taneous adipose tissues tend to increase with the
increase in BMI (Figure 7).
Discussion
Obesity is a common nutritional disorder, which is char-
acterized by excess accumulation of body fat, and is
known to be associated with increased susceptibility for
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diabetes (T2DM) [16,17]. It has been suggested that
obesity can be considered as a hypertrophic disease
resulted from an increase in the number or the size of
adipocytes. Adipocytes are derived from the fibroblast-
like preadipoctes though cell differentiation, and
Figure 1 Adipose differentiation of 3T3-L1 preadipocytes. Adipose differentiation of 3T3-L1 preadipocytes was induced as described in
Materials and Methods. (A) Adipose differentiation of 3T3-L1 preadipocytes evaluated by Oil-red-O staining of lipid droplets. (B) Quantitative
analysis of the intracellular Oil-red-O by spectrophotometry. (C) PPAR-g and ALBP mRNA expression at different stages of 3T3-L1 preadipoytes
differentiation. (D) Quantitative analyses of PPAR-g and ALBP mRNA levels at different stages of 3T3-L1 preadipoytes differentiation. Each
experiment was repeated at least three times. *P < 0.05 vs. preadipocytes before induction.
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pocytes have been implicated in obesity development
[18].
Thyroid-stimulating hormone (TSH) is a hormone
released from the anterior pituitary, which is the main
regulator of thyroid growth and function. The action of
TSH is known to be mediated by thyroid-stimulating
hormone receptor (TSHR) that belongs to the G protein
coupled receptor family [19]. In addition to thyroid,
TSHR has been proven to be expressed in fat cells. Sev-
eral studies have suggested that TSHR expression in adi-
pocytes may play an important role in adipogenesis. T.
Onaya reported that the differentiation of rat preadipo-
cytes was accompanied by an increased expression of
TSHR [7]. Similar results were also observed in human
orbital preadipocyte fibroblasts [13,14] and in mouse
embryonic stem cells [15]. In the present study, we
showed that TSHR expression increases with the adi-
pose differentiation of 3T3-L1 preadipocytes. Our results
are in agreement with previous observations [20-22].
Additionally, we showed that knockdown of TSHR
delayed the adipocyte differentiation of 3T3-L1 preadi-
pocytes, thus further confirming that TSHR is a possible
regulator of adipogenesis.
To investigate the possible involvement of TSHR in
the pathogenesis of obesity, we analyzed the TSHR
expression profile in adipose tissues in mice. We estab-
lished obesity model in C57/BL6 mice with high fat diet
as described previously [23-25]. The successful establish-
ment of obese model was confirmed by the significantly
increased body weight and higher serum CHOL levels
in obesity mice after 14 weeks of diet induction. Finally,
TSHR protein expression in visceral adipose tissue was
analyzed, and results showed that the average TSHR
protein level in obese mice was higher compared to the
non-obesity control mice. These findings suggest that
diet-induced obesity is associated with an upregulation
of TSHR expression in adipose tissue. However, we also
found that TSHR protein expression was not increased
in all obese mice. The mechanism for this discrepancy is
not clear, which may reflect the complexity in obesity
development.
In addition to animal experiment, TSHR expression in
adipose tissues was further investigated in human sam-
ples. Subcutaneous adipose tissues from individuals with
different BMI were used for TSHR determination. We
found that the TSHR expression level was higher in
people with BMI > 25 than that of those with BMI < 25.
Taken together, this study demonstrated that TSHR
plays an important role in adipocyte differentiation. The
TSHR expression in adipose tissues is associated with
diet- induced obesity in mice and increases with increas-
ing BMI in human. Our findings suggest that dysregu-
lated TSHR expression might be implicated in obesity
development under certain circumstances, which may
involve a mechanism of excess adipogenesis.
Figure 2 TSHR mRNA expression profile during the adipose differentiation of 3T3-L1 preadipocytes. (A) TSHR mRNA levels at different
time points of differentitaiton determied by RT-PCR. (B) Quantitative analyses of TSHR mRNA levels determied by RT-PCR. The experiment was
repeated three times. *P < 0.05 vs. preadipocytes before induction.
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Page 4 of 12Figure 3 TSHR protein expression profile during the adipose differentiation of 3T3-L1 preadipocytes. (A) TSHR protein levels at different
time points of differentitaiton determied by Western blot. (B) Quantitative analyses of TSHR mRNA levels determied by Western blot. (C)
Representative photos of immuno-fluorescence staining for TSHR protein under Laser scanning confocal microscope. (D) Quantitative analysis of
the fluorescence intensities of the differentiated adipocytes (12 days after induction) and undifferentiated 3T3-L1 preadipocytes. The average
fluorescence intensity of the undifferentiated 3T3-L1 preadipocytes was designated as 1.
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Materials
The mouse embryo fibroblasts 3T3-L1 was obtained from
the American Type Culture Collection (ATCC). Medium
a n ds e r u mw e r ep u r c h a s e df r o mG I B C O( I n v i t r o g e n ,
USA). Anti-TSHR and anti-b-actin antibodies were pur-
chased from Santa Cruz (Cambridge, UK). All primers
used in this study were synthesized in Genomics Institute
of HuaDa in Beijing. All other reagents were purchased
from Sigma (St. Louis, MO, USA).
Cell culture, preadipocyte differentiation induction
3T3-L1 preadipocytes were maintained in Dulbecco’s
Modified Eagle Medium (DMEM) supplemented with
5% calf serum, 100 U/mL penicillin and 100 mg strepto-
mycin at 37°C in a humidified atmosphere composed of
95% air and 5% CO2. To induce differentiation, conflu-
ent preadipocytes were treated for 2 days with insulin
(10 μM), isobutylmethylxanthine (IBMX) (0.5 mM), and
dexamethasone (0.25 μM) in DMEM containing 10%
FCS, followed by treatment for another 2 days with
insulin (10 μM) alone in DMEM containing 10% FCS.
Afterwards, cells were replenished with DMEM contain-
ing 10% FCS every other day. 10~12 days later, approxi-
mate 80% cells were differentiated into adipocytes.
Oil-Red-O staining
After removal of culture medium, cells were washed three
times with phosphate buffered saline (PBS) and fixed with
4% formaldehyde at room temperature for 10 min. After
washing with PBS, cells were then stained with freshly
diluted Oil-Red-O solution (6 parts of 0.1% Oil-Red-O in
isopropyl alcohol and 4 parts of water) for 30min. Cells
were then washed twice with 60% isopropyl alcohol for 1
min each, and washed once with PBS. Images were
acquired under the inverted phase contrast microscope.
For quantitative analysis, Oil-Red-O staining was dissolved
with isopropyl alcohol and the optical density was mea-
sured at 510 nm by spectrophotometry. All experiments
were performed in triplicate.
Confocal fluorescence microscopy analysis
3T3-L1 preadipocytes were induced to differentiate for as
described above. Cells were fixed in 4% formaldehyde for
15 min and blocked in PBS containing 3% BSA 30 min at
37°C in a humidified atmosphere. Subsequently, the cells
were incubated for 16~18 h at 4°C with primary anti-
TSHR antibody (1:200 dilution), followed by incubation
with Fluorescein isothiocyanate (FITC)-labeled rabbit-
anti-goat secondary antibody (1:200) for 30 min. After
washing, cells were mounted with DAPI-containing
mounting medium, and analyzed by confocal microscope
(TCS SPE, Leica, Germany). For quantitative analysis of
the TSHR expression, the fluorescence intensity of at least
25 randomly selected cells from the differentiated adipo-
cytes (12days after induction) and undifferentiated 3T3-L1
preadipocytes was measured using the MetaMorph soft-
ware (Universal Imaging Corporation, West Chester, PA).
Figure 4 Tshr gene knockdown in 3T3-L1 preadipocytes. 3T3-L1 preadipocytes were treated with siRNA or empty vector, respectively. After
the selection of stable transfectants, TSHR mRNA and protein levels were determined by RT-PCR and Western blot.
Lu et al. Lipids in Health and Disease 2012, 11:17
http://www.lipidworld.com/content/11/1/17
Page 6 of 12Figure 5 Influence of Tshr gene knockdown on 3T3-L1 preadipocytes differentiation. Stable transfected 3T3-L1 preadipocytes were
induced to differentiate. Cell differentiation status was evaluated by analysis of endogenous lipid accumulation (A) and PPAR-g and ALBP mRNA
expression (B-E).
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The siRNA targeting to TSHR was generated by using
the lentivirus vector pLentiLox 3.7 according to the
manufacturer’s instruction. Briefly, the oligo sequences
of the siRNA targeting to TSHR were as follows:
oligo-F: 5’-AACGTACAACAATGGATTTACTTT-
CAAGAGAAGTAAATCCATTGTTGTACTTTTTC-3’
oligo-R: 5’-TCGAGAAAAAGTACAACAATGGATTT
ACTTCTCTTGAAAGTAAATCCATTGTTGTACG
TT-3’ The sequence targeting the TSHR gene-coding
region were annealed and inserted into pLentiLox 3.7
vector between Xho I and Hpa I to generate the siRNA
expression vector. The obtained plasmids (pLentiLox 3.7
siRNA-TSHR) were then used to generate lenti-virus
encoding siRNA targeting to TSHR in 293T cells. pLen-
tiLox 3.7 vector was used to generate non siRNA virus
as control.
Plasmids (pLentiLox 3.7 siRNA-TSHR and pLentiLox
3.7) were transfected into 293T cells for packaging two
viruses according to manufacture’s protocol. 48 h later,
the supernatants containing virus were used to infect
3T3-L1 when cells reached 80~90% confluence. 24
hours post infection, stable transfectants were selected.
Cells with stable expression of pLentiLox 3.7 vector
were used as controls.
Obesity mice induction and analysis
Twenty-four adult male C57/BL6 mice aged 6 weeks
were purchased from the Experimental Animal Center
of Shandong University. Animal experiments were in
accord to the ‘Principles of laboratory animal care’
established by the National Institutes of Health, and
approved by the “Animal Care and Use Committee” of
t h eS h a n d o n gU n i v e r s i t y( n u m b e rE C A E S D U S M
2011037). Mice were maintained in a controlled envir-
onment at 25°C and 55% relative humidity environment
Table 1 Metabolic parameters of control and High-fat
diet mice
Variables Basal diet-fed
control mice
High fat diet-fed
obese mice
P value
n1 0 6
Body weight (g) 25.82 ± 1.05 37.66 ± 3.64 P < 0.05
AST (IU/L) 205.2 ± 7.33 204.8 ± 27.89 P > 0.05
TG (mmol/L) 0.97 ± 0.15 0.94 ± 0.11 P > 0.05
CHOL (mmol/L) 1.61 ± 0.31 3.41 ± 0.24 * P < 0.05
GLU (mmol/L) 4.36 ± 0.83 8.55 ± 0.6 * P < 0.05
Data are means ± SE. *P < 0.05, control vs. High-fat diet mice.
Figure 6 Increased TSHR protein expression in visceral adipose tissues from diet-induced obese mice. Visceral fat around the kidneys
were extracted from both diet-induced obese mice and non-obese mice. TSHR protein level was determined by Western blot. (A) Representative
result from Western blot analysis of TSHR protein expression. (B) Quantitative analysis of TSHR protein expression. The experiment was repeated
three times.
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Page 8 of 12with free access to tape water and food. After one week
of adaptation, mice were randomly divided into two
groups, the “high-fat group” and the “control group”,
and fed for 14 weeks with different rodent diets. The
control diet contained 4% fat while high-fat diet con-
tained 20% fat. Compositions of both control and high-
fat diets were based on the basal diet, which was
detected by Pony Testing International Group (Table 2).
The “high-fat group” was fed with high-fat diet, while
the “control group” was fed with control diet. The body
weight of each animal was monitored once a week. The
animals were sacrificed after deep anesthesia. Blood was
Figure 7 Correlation between BMI and TSHR protein expression in human subcontaneous adipose tissues. TSHR protein expression in
human subcontaneous adipose tissues was analyzed by Western Blot. (A, B) Representative results from Western blot analysis of TSHR protein
expression. (C) Quantitative analysis of TSHR protein expression based on BMI.
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Page 9 of 12collected in EDTA-coated tubes after fasting the mice
for 12 hr, serum was separated by centrifugation (500×g,
4°C, 10 min). Serum cholesterol (CHOL), triglycerides
(TG), aspartate transaminase (AST) and serum glucose
(GLU) levels were measured using the Beckman DXC
800 analyzer (American). All these biochemical mea-
surements were carried out in the Lab of Clinic Exam in
Shandong Provincial Hospital. Visceral adipose tissues
near the kidneys were collected and quickly frozen by
immediate immersion in liquid nitrogen, and stored at
-80°C for protein extraction.
Human fat sample collection
Adipose tissue samples were collected from patients with
benign cernical lesions who underwent surgeries in the
Department of Otolaryngology Division of Head and
Neck Surgery in Shandong Provincial Hospital Affiliated
to Shandong University. 120 patients were recruited in
this study, which included 21 cases with obstructive sleep
apnea-hyperpnoea syndrome (OSAHS), 51 cases with
benign tumor of parapharyngeal space (BMPS), 30 cases
with branchial cleft cyst (BCC) and 18 cases with thyro-
glossal tract cyst (TTC). The basic clinical characteristics
of these patients were shown in Table 3. All these
patients were euthyroid, and had no history of diabetes
and no family history of obesity. These patients were
divided in 4 groups based on their BMI (Body Mass
Index, calculated as body weight (BW, kg) over squared
height in meter): slim group (25 cases), BMI ≤ 20; normal
group (33 cases), 20 < BMI < 25; overweight group (34
cases), 25 ≤ BMI < 30; obesity group (28 cases), BMI ≥
30. Written informed consent was obtained from all
patients before surgery. All patients were operated under
general anesthesia. Adipose tissues were got from the
subcutaneous areas in the necks. The study was approved
by the Ethics Committees of Shandong University (num-
ber MECSDUMS 2011055).
Adipose tissue pretreatment
Adipose tissues contain a large amount of lipids, which
can disturb the processes for RT-PCR and Western-blot
analyses. In the present study, we used a method to
remove the majority of triglycerides from adipose tissues
before further analyses. Briefly, about 50mg adipose tis-
sues was cut into small pieces and homogenized with
100~200 μl RIPA (radio-immune precipitation buffer
containing protein inhibitor) in a homogenizer. The
lysate was transferred into 1.5ml Eppendorf tubes and
mixed with ten times volume of pre-cooled acetone and
shaken for 10 times. The mixture was centrifuged at
12000 g for 1 ~ 2 h at 4°C. Lipid droplets always
appeared in the upper layer, and other components of
cells always stayed in the bottom of the tube. The upper
lipid droplets was removed and discarded. The same pro-
cedure can be repeated until lipids are effectively
removed.
RT-PCR
Total RNA was extracted using TRIZOl (Invitrogen) from
adipocytes cells or primary adipose tissues. M-MuL V
reverse transcription (Takara) was used for mRNA mea-
surements. In brief, RT was performed by using the
ExScript RT reagent kit (Takara Bio, Otsu, Shiga, Japan) in
a final volume of 20 μLc o n t a i n i n g1μgt o t a lR N A ,4μL
5×ExScript buffer, 1 μL deoxynucleotide triphosphate
(dNTP, 10 μM) mixture, 1 μL Oligo (dT) primer, 0.5 μL
ExScript RTase, 0.5 L RNase inhibitor, and RNase-free
water to a volume of 20 μL. PCR was conducted according
to the instructions of Takara Taq TM under the following
conditions: pre-DNA denaturation at 95°C for 3 minutes;
DNA denaturation at 95°C for 45 seconds; annealing for
40 seconds at temperatures: 53°C for Tshr, 55°C for ALBP
or PPAR-g, and 60°C for GAPDH; elongation is carried
out at 72°C for 50 seconds, the total cycle number is 30.
All experiments were performed in triplicate. The relative
OD ratio was calculated using the NIH Image J software
with GAPDH as an internal control. Primers used in the
experiments were shown in Table 4.
Western blot analysis
Samples were homogenized in RIPA lysis buffer contain-
ing protease and phosphatase inhibitors. Protein concen-
tration was determined by Bradford method. Proteins
Table 2 Contents of commercial basal diet detection.
Ingredients Limit Test Content
Moisture (%) ≤ 10 7.0
Protein (%) ≥ 18 20.1
Fat (%) ≥ 4 5.1
Fiber (%) ≤ 5 4.74
Ash (%) ≤ 8 6.67
Calcium (%) 1.0~1.8 1.19
Phosphor (%) 0.6~1.2 0.82
Arsenic (mg/kg) ≤ 0.7 0.36
Ab (mg/kg) ≤ 1.0 0.13
Cadmium (mg/kg) ≤ 0.2 0.098
Not detected Hg, BHC, DDT and Aflatoxin B1.
Table 3 Human samples information collected from clinic.
BMI Number Sex benign cernical lesions
male female OSAHS BMPS BCC TTC
BMI ≤ 20 25 11 14 0 13 6 6
20 < BMI ≤ 25 39 18 21 1 18 15 5
25 < BMI ≤ 30 34 14 20 8 17 4 5
BMI > 30 22 14 8 12 3 5 2
Total number 120 57 63 21 51 30 18
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gels and transferred to a Hybond-P PVDF membrane.
Subsequently, the membrane was blocked in 5% nonfat
milk for 1 hour and incubated with anti-TSHR (1:1000)
or anti-b-actin(1:2000) primary antibodies overnight at
4°C, followed by incubation with the peroxidase-conju-
gated anti-goat or anti-mouse secondary antibody
(1:5000 dilution) for 1 h at room temperature. After
washing with PBS, the bound primary antibody was
visualized with the Chemiluminescence System (Super-
Signal West Pico Chemiluminescent Substrate) (all from
Pierce) and exposed to film. The relative intensity of
TSHR to b-actin was analyzed with the Image J
software.
Statistical analysis
Data were presented as mean ± standard error of the
mean (SEM). One-way analysis of variance (ANOVA)
and T test were performed using the SPSS 13.0 software
package. P < 0.05 was considered statistically significant.
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